Oppenheimer Upgrades Sarepta Therapeutics (SRPT) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. ADYYF
9. TPR
10. DGNX

May 14, 2024 6:10 AM EDT
Get Alerts SRPT Hot Sheet
Price: $18.00 -2.28%

Rating Summary:
    19 Buy, 18 Hold, 6 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE

Oppenheimer analyst Hartaj Singh upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Perform to Outperform with a price target of $180.00.


For an analyst ratings summary and ratings history on Sarepta Therapeutics click here. For more ratings news on Sarepta Therapeutics click here.


Shares of Sarepta Therapeutics closed at $131.70 yesterday.


You May Also Be Interested In





Related Categories

Upgrades